Clinical Trial Update: Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial assessing ICE chemotherapy (Ifosfamide, Carboplatin, Etoposide) with Brentuximab vedotin (SGN-30) in young patients with recurrent Anaplastic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anaplastic Large Cell Lymphoma, Recurrent Childhood Anaplastic Large Cell Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-01-01